schliessen

Filtern

 

Bibliotheken

Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals with self-reported ca... Full description

Journal Title: The Lancet Global Health March 2018, Vol.6(3), pp.e292-e301
Main Author: Murphy, Adrianna
Other Authors: Palafox, Benjamin , O'Donnell, Owen , Stuckler, David , Perel, Pablo , Alhabib, Khalid F , Avezum, Alvaro , Bai, Xiulin , Chifamba, Jephat , Chow, Clara K , Corsi, Daniel J , Dagenais, Gilles R , Dans, Antonio L , Diaz, Rafael , Erbakan, Ayse N , Ismail, Noorhassim , Iqbal, Romaina , Kelishadi, Roya , Khatib, Rasha
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 2214-109X ; E-ISSN: 2214-109X ; DOI: 10.1016/S2214-109X(18)30031-7
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: elsevier_sdoi_10_1016_S2214_109X_18_30031_7
title: Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
format: Article
creator:
  • Murphy, Adrianna
  • Palafox, Benjamin
  • O'Donnell, Owen
  • Stuckler, David
  • Perel, Pablo
  • Alhabib, Khalid F
  • Avezum, Alvaro
  • Bai, Xiulin
  • Chifamba, Jephat
  • Chow, Clara K
  • Corsi, Daniel J
  • Dagenais, Gilles R
  • Dans, Antonio L
  • Diaz, Rafael
  • Erbakan, Ayse N
  • Ismail, Noorhassim
  • Iqbal, Romaina
  • Kelishadi, Roya
  • Khatib, Rasha
subjects:
  • Public Health
ispartof: The Lancet Global Health, March 2018, Vol.6(3), pp.e292-e301
description: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals with self-reported cardiovascular disease from 21 countries enrolled in the Prospective Urban Rural Epidemiology (PURE) study. Defining one or more drugs as a minimal level of secondary prevention, wealth-related inequality was measured using the Wagstaff concentration index, scaled from −1 (pro-poor) to 1 (pro-rich), standardised by age and sex. Correlations between inequalities and national health-related indicators were estimated. The proportion of patients with cardiovascular disease on three medications ranged from 0% in South Africa (95% CI 0–1·7), Tanzania (0–3·6), and Zimbabwe (0–5·1), to 49·3% in Canada (44·4–54·3). Proportions receiving at least one drug varied...
language: eng
source:
identifier: ISSN: 2214-109X ; E-ISSN: 2214-109X ; DOI: 10.1016/S2214-109X(18)30031-7
fulltext: fulltext
issn:
  • 2214-109X
  • 2214109X
url: Link


@attributes
ID1648612544
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordiddoi_10_1016_S2214_109X_18_30031_7
sourceidelsevier_s
recordidTN_elsevier_sdoi_10_1016_S2214_109X_18_30031_7
sourcesystemPC
dbid
0.FO
10SF
21P~
3457
46I.
5AAEDT
6AAFTH
7AEVXI
8AFTJW
9AGHFR
10AITUG
11AJUYK
12FDB
13IXB
14OD.
15OO~
16SSZ
17Z5R
pqid2001914052
display
typearticle
titleInequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
creatorMurphy, Adrianna ; Palafox, Benjamin ; O'Donnell, Owen ; Stuckler, David ; Perel, Pablo ; Alhabib, Khalid F ; Avezum, Alvaro ; Bai, Xiulin ; Chifamba, Jephat ; Chow, Clara K ; Corsi, Daniel J ; Dagenais, Gilles R ; Dans, Antonio L ; Diaz, Rafael ; Erbakan, Ayse N ; Ismail, Noorhassim ; Iqbal, Romaina ; Kelishadi, Roya ; Khatib, Rasha
ispartofThe Lancet Global Health, March 2018, Vol.6(3), pp.e292-e301
identifier
subjectPublic Health
descriptionThere is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals with self-reported cardiovascular disease from 21 countries enrolled in the Prospective Urban Rural Epidemiology (PURE) study. Defining one or more drugs as a minimal level of secondary prevention, wealth-related inequality was measured using the Wagstaff concentration index, scaled from −1 (pro-poor) to 1 (pro-rich), standardised by age and sex. Correlations between inequalities and national health-related indicators were estimated. The proportion of patients with cardiovascular disease on three medications ranged from 0% in South Africa (95% CI 0–1·7), Tanzania (0–3·6), and Zimbabwe (0–5·1), to 49·3% in Canada (44·4–54·3). Proportions receiving at least one drug varied...
languageeng
oafree_for_read
source
version7
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
linktorsrc$$Uhttps://www.sciencedirect.com/science/article/pii/S2214109X18300317$$EView_full_text_in_ScienceDirect
search
creatorcontrib
0Murphy, Adrianna
1Palafox, Benjamin
2O'Donnell, Owen
3Stuckler, David
4Perel, Pablo
5Alhabib, Khalid F
6Avezum, Alvaro
7Bai, Xiulin
8Chifamba, Jephat
9Chow, Clara K
10Corsi, Daniel J
11Dagenais, Gilles R
12Dans, Antonio L
13Diaz, Rafael
14Erbakan, Ayse N
15Ismail, Noorhassim
16Iqbal, Romaina
17Kelishadi, Roya
18Khatib, Rasha
titleInequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
description

There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development.

We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals with self-reported cardiovascular disease from 21 countries enrolled in the Prospective Urban Rural Epidemiology (PURE) study. Defining one or more drugs as a minimal level of secondary prevention, wealth-related inequality was measured using the Wagstaff concentration index, scaled from −1 (pro-poor) to 1 (pro-rich), standardised by age and sex. Correlations between inequalities and national health-related indicators were estimated.

The proportion of patients with cardiovascular disease on three medications ranged from 0% in South Africa (95% CI 0–1·7), Tanzania (0–3·6), and Zimbabwe (0–5·1), to 49·3% in Canada (44·4–54·3). Proportions receiving at least one drug varied...

subjectPublic Health
general
0English
1Elsevier Ltd
210.1016/S2214-109X(18)30031-7
3ScienceDirect (Elsevier)
4ScienceDirect Journals (Elsevier)
sourceidelsevier_s
recordidelsevier_sdoi_10_1016_S2214_109X_18_30031_7
issn
02214-109X
12214109X
rsrctypearticle
creationdate2018
addtitleThe Lancet Global Health
searchscope
0elsevier_full
1elsevier4
2elsevier2
scope
0elsevier_full
1elsevier4
2elsevier2
lsr45$$EView_full_text_in_ScienceDirect
tmp01ScienceDirect Journals (Elsevier)
tmp02
0.FO
10SF
21P~
3457
46I.
5AAEDT
6AAFTH
7AEVXI
8AFTJW
9AGHFR
10AITUG
11AJUYK
12FDB
13IXB
14OD.
15OO~
16SSZ
17Z5R
startdate20180301
enddate20180331
lsr40The Lancet Global Health, March 2018, Vol.6 (3), pp.e292-e301
doi10.1016/S2214-109X(18)30031-7
citationpf e292 pt e301 vol 6 issue 3
lsr30VSR-Enriched:[pqid]
sort
titleInequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
authorMurphy, Adrianna ; Palafox, Benjamin ; O'Donnell, Owen ; Stuckler, David ; Perel, Pablo ; Alhabib, Khalid F ; Avezum, Alvaro ; Bai, Xiulin ; Chifamba, Jephat ; Chow, Clara K ; Corsi, Daniel J ; Dagenais, Gilles R ; Dans, Antonio L ; Diaz, Rafael ; Erbakan, Ayse N ; Ismail, Noorhassim ; Iqbal, Romaina ; Kelishadi, Roya ; Khatib, Rasha
creationdate20180300
lso0120180300
facets
frbrgroupid6875559525021471794
frbrtype5
newrecords20190904
languageeng
topicPublic Health
collectionScienceDirect (Elsevier)
prefilterarticles
rsrctypearticles
creatorcontrib
0Murphy, Adrianna
1Palafox, Benjamin
2O'Donnell, Owen
3Stuckler, David
4Perel, Pablo
5Alhabib, Khalid F
6Avezum, Alvaro
7Bai, Xiulin
8Chifamba, Jephat
9Chow, Clara K
10Corsi, Daniel J
11Dagenais, Gilles R
12Dans, Antonio L
13Diaz, Rafael
14Erbakan, Ayse N
15Ismail, Noorhassim
16Iqbal, Romaina
17Kelishadi, Roya
18Khatib, Rasha
jtitleLancet Global Health
creationdate2018
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Murphy
1Palafox
2O'Donnell
3Stuckler
4Perel
5Alhabib
6Avezum
7Bai
8Chifamba
9Chow
10Corsi
11Dagenais
12Dans
13Diaz
14Erbakan
15Ismail
16Iqbal
17Kelishadi
18Khatib
aufirst
0Adrianna
1Benjamin
2Owen
3David
4Pablo
5Khalid F
6Alvaro
7Xiulin
8Jephat
9Clara K
10Daniel J
11Gilles R
12Antonio L
13Rafael
14Ayse N
15Noorhassim
16Romaina
17Roya
18Rasha
auinitA
auinit1A
au
0Murphy, Adrianna
1Palafox, Benjamin
2O'Donnell, Owen
3Stuckler, David
4Perel, Pablo
5Alhabib, Khalid F
6Avezum, Alvaro
7Bai, Xiulin
8Chifamba, Jephat
9Chow, Clara K
10Corsi, Daniel J
11Dagenais, Gilles R
12Dans, Antonio L
13Diaz, Rafael
14Erbakan, Ayse N
15Ismail, Noorhassim
16Iqbal, Romaina
17Kelishadi, Roya
18Khatib, Rasha
atitleInequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
jtitleThe Lancet Global Health
risdate201803
volume6
issue3
spagee292
epagee301
pagese292-e301
issn2214-109X
eissn2214-109X
formatjournal
genrearticle
ristypeJOUR
abstract

There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development.

We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals with self-reported cardiovascular disease from 21 countries enrolled in the Prospective Urban Rural Epidemiology (PURE) study. Defining one or more drugs as a minimal level of secondary prevention, wealth-related inequality was measured using the Wagstaff concentration index, scaled from −1 (pro-poor) to 1 (pro-rich), standardised by age and sex. Correlations between inequalities and national health-related indicators were estimated.

The proportion of patients with cardiovascular disease on three medications ranged from 0% in South Africa (95% CI 0–1·7), Tanzania (0–3·6), and Zimbabwe (0–5·1), to 49·3% in Canada (44·4–54·3). Proportions receiving at least one drug varied...

pubElsevier Ltd
doi10.1016/S2214-109X(18)30031-7
lad01The Lancet Global Health
oafree_for_read
date2018-03